D-dimer, a breakdown product of cross-linked fibrin has been extensively evaluated as a diagnostic test for acute venous thromboembolism. Rapid, highly sensitive D-dimer assays are now available that are suitable for testing in the emergency setting. Preliminary studies suggest that when using a highly sensitive D-dimer assay, a negative test result may be sufficient to exclude the diagnosis of venous thromboembolism without need for further testing. Less sensitive, but more specific D-dimer assays are also available. The negative predictive value of these latter assays is insufficient to exclude venous thromboembolism on the basis of a negative test result alone. However, their utility is increased by identifying patient populations at low risk for venous thromboembolism using consideration of clinical probability or radiographic testing. Further, large multicenter management studies are required to confirm the safety of relying on a negative D-dimer result to exclude the diagnosis of venous thromboembolism.
Venous thromboembolism (a composite of deep vein thrombosis and/or pulmonary embolism) is a common disorder with considerable morbidity and potential for mortality. Timely diagnostic testing must be performed to insure that antithrombotic therapy is initiated for patients confirmed to have venous thromboembolism and its risks are avoided if the diagnosis is excluded [1, 2] .
Since the introduction of monoclonal antibody technology, there has been considerable interest in identifying surrogate hematologic parameters that might assist with the diagnosis of venous thromboembolism. Of these, Ddimer is the most sensitive and has been the most extensively investigated [1, 3] . D-dimer is a specific breakdown product of the fibrin blood clot. The presence of D-dimer indicates the occurrence plasmin mediated lysis of cross-linked fibrin. Elevated D-dimer levels are observed in patients who develop venous thromboembolism. However, D-dimer levels may also be increased in other settings that result in fibrin generation including recent surgery, major hemorrhage, trauma, cancer, and pregnancy [1, 3] D-dimer assays D-dimer assays base their endpoint on the detection of D-dimer fragments using target specific monoclonal antibodies. The various D-dimer assays differ in two major ways: 1) the specific D-dimer epitope to which the monoclonal antibody is directed; and 2) the testing methodology used by the assay kit [4] . Until recently, two types of D-dimer assay methodologies were available; membrane plate enzyme-linked immunoabsorbent assays (ELISAs) and manual qualitative latex agglutination assays. Early ELISA D-dimers were very sensitive but nonspecific assays. However, the prolonged turnaround time and need for batch testing to minimize expense have greatly limited the use of these assays for routine clinical use. Early latex agglutination D-dimer assays were designed for the diagnosis of disseminated intravascular coagulation and required manually reading. Evaluations of these first latex agglutination assays revealed their sensitivities were too low for them to be used as diagnostic tests for venous thromboembolism [1, 4] .
During the past 5 years a number of new D-dimer assays have been evaluated for clinical use. Rapid ELISA methods using immunofluorescence or immunofiltration techniques are now available that can provide results within 30 minutes. More sensitive, fully automated, semi-quantitative latex agglutination assays that use turbimetric or agglutination endpoints have been developed that provide results within 10 minutes. In addition, a whole blood D-dimer kit has been developed that is suitable for bedside testing.
Two recent studies [5•,6] have compared the accuracy of currently available D-dimer assays in cohorts of patients with suspected deep vein thrombosis and pulmonary embolism. Each of these studies used gold standard diagnostic tests to confirm the diagnosis of venous thromboembolism in all patients. Van der Graff et al. [5•] compared the accuracy of 13 D-dimer methods in 99 outpatients with suspected deep vein thrombosis (Table 1 ). They reported that three rapid ELISA assay methods were comparably accurate to three membrane plate ELISA assays, with sensitivities varying from 94% to 100%. Three semiquantitative immunoturbimetric and one automated latex agglutination assays had sensitivities between 89% and 100%, however, a fifth automated latex agglutination assay appeared to be less sensitive. One qualitative latex agglutination assay and a whole blood agglutination assay had sensitivities of about 80%. Most of the highly sensitive assays were less specific than the less sensitive qualitative and turbimetric assays. Specificities ranged from 31% to 62% for ELISA, 31% to 91% for semiquantitative latex agglutination and turbimetric methods, and were 90% and 94% for the two qualitative agglutination methods (Table  1) 
Similar findings were noted by Freyburger et al.
[6] who evaluated 10 different D-dimer assays in 100 inpatients with suspected deep vein thrombosis or pulmonary embolism. Although clear differences exist between the sensitivity and specificity of different D-dimer assays, a recent meta-analysis demonstrated that the accuracies as determined by the receiver operating curves were similar [7] . Trade-offs exist between the sensitivity and specificity of these assays. D-dimer assays with sensitiv-ity levels approaching 100% for the diagnosis of venous thromboembolism are far less specific than less sensitive assays.
Regardless of the D-dimer assay chosen, a positive test result is not of sufficient predictive value to confirm the presence of venous thromboembolism. The potential value of the D-dimer assay is for a negative test to exclude the diagnosis of venous thromboembolism and to eliminate or minimize the need for further diagnostic testing [1] [2] [3] [4] .
Use of D-dimer for the diagnosis of pulmonary embolism
Currently, the methods available to diagnose pulmonary embolism are suboptimal. Two imaging procedures, ventilation-perfusion lung scanning and spiral computerized tomography (spiral CT) are commonly used in clinical practice, and neither are sufficiently accurate to confirm or exclude pulmonary embolism on the basis of a single test result in most patients [8, 9] . Pulmonary angiography, the gold standard test for pulmonary embolism, is a more technically demanding test that is not without risk and is unavailable in many centers. Pulmonary angiography's role primarily has been to confirm the presence of pulmonary embolism when the lung scan or spiral CT are non-diagnostic [9] .
Recent studies have demonstrated the considerable potential for D-dimer to improve on diagnostic algorithms for patients with suspected pulmonary embolism ( Table 2) . Because of its very high sensitivity, a negative ELISA or highly sensitive immunoturbimetric D-dimer assay alone may potentially be used to exclude the diagnosis. Perrier et al. [10••] performed a management study and reported that no thromboembolic complications were observed in a 3-month follow-up period in 159 symptomatic patients presenting to the emergency To date, only one small management study [15] has been published evaluating the role of a negative SimpliRED D-dimer assay to exclude the diagnosis of pulmonary embolism in 245 unselected inpatients or outpatients with suspected pulmonary embolism. Antithrombotic therapy was withheld from patients who were not considered to be at high clinical likelihood for pulmonary embolism who had non-diagnostic lung scans, negative SimpliRED Ddimer, and normal venous ultrasonography. One of 66 such patients (1.5%; 95% CI, 0% to 8%) has a possible venous thromboembolic complication in a three month follow-up period. The sensitivity of the SimpliRED D-dimer in this cohort was 89% in this cohort [15] .
Use of D-dimer to diagnose deep vein thrombosis
Venous ultrasound imaging is the radiographic test of choice to diagnose deep vein thrombosis in symptomatic patients [1] [2] [3] . Although highly sensitive and specific for the diagnosis of deep vein thrombosis involving the proximal leg veins, ultrasonography is much less accurate for deep vein thrombosis localized to the veins of the calf. Serial ultrasound testing during a 1-week period has been validated and widely recommended as a safe approach to manage patients who have an initially normal ultrasound in order to identify patients with calf thrombi that subsequently extend into the proximal venous system. The drawback of this approach is that very few patients (1% to 2% in recent studies) with suspected deep vein thrombosis and a negative initial ultrasound will be confirmed to have deep vein thrombosis on serial testing [16, 17] .
Recently, D-dimer has been demonstrated to be a useful test to limit the need for serial ultrasonography testing in patients with suspected deep vein thrombosis (Table 2) . Bernardi et al. [18] reported that in 598 outpatients with suspected deep vein thrombosis, those with a single normal ultrasound and a negative immunofiltration ELISA D-dimer (Instant I-A, Stago, France) had a very low rate of subsequent venous thromboembolic complications during a 3-month period (0.4%; 95%, CI: 0% to 0.9%). The safety of this approach was subse- Ginsberg et al. [19] reported that among 273 outpatients with suspected deep vein thrombosis who had a negative impedance plethysmography study and SimpliRED D-dimer, only four (1.5%; 95% CI 0.4% to 3.7%) had venous thromboembolic complications in a three month follow-up period. When this cohort was restricted to patients at low pretest probability, the complication rate was only 0.6%.
Ongoing studies are evaluating the safety of relying on a negative D-dimer to exclude the diagnosis of deep vein thrombosis without the need for diagnostic imaging. Similar to studies evaluating patients with pulmonary embolism, the safety of this approach would be expected to depend upon the sensitivity of the Ddimer assay and the prevalence of disease in the patients under study. Wells et al. [20] have demonstrated that the negative predictive value of the SimpliRED D-dimer varied depending upon the clinical pre-test probability. In a cohort of about 500 outpatients with suspected deep vein thrombosis who underwent ultrasound imaging and SimpliRED D-dimer assay testing, the overall negative predictive value was 98.3%. However, the negative predictive value varied from 99.5% (95% CI, 97.3% to 100%) in patients in the low probability category to 85.7% (95% CI, 42% to 99.6%) in the high probability group. Two other recent studies [22, 23] have confirmed these findings, demonstrating that the negative predictive value for the SimpliRED D-dimer for excluding proximal deep vein thrombosis is over 99% in patients considered a low clinical probability and less in patients at higher clinical probability for deep vein thrombosis.
Problematic settings for use of D-dimer
Although D-dimer has great potential for improving the management of patients with suspected venous thromboembolism, recent studies have identified patient populations and clinical settings in which the accuracy of D-dimer is lower. Two recent studies [11, 23] performed in the inpatient setting, while concurrent studies were performed on outpatients, have demonstrated that the specificity of both highly sensitive and less sensitive D-dimer assays is reduced in hospitalized patients [10, 24] . Lower specificity results in increased number of false positive results and limits the diagnostic utility of D-dimer ( There may also be assay specific factors that influence the accuracy of D-dimer testing. For example, with the SimpliRED assay interobserver variability in test results among experienced personnel is high [27, 28] . However, one study [28] . has reported significantly lower sensitivity for the SimpliRED D-dimer using test results drawn from citrated whole blood compared to fingerstick samples.
In a separate study [29] , evaluating a qualitative latex agglutination D-dimer for the diagnosis of deep vein thrombosis, significantly higher sensitivity was observed when testing was performed by an experienced research technologist compared with technologists from a clinical hematology laboratory (84% versus 61%, P < .05) although specificity results were similar in the two groups. Laboratory technical experience may account for some of the widely discrepant accuracy results reported between studies using identical qualitative Ddimer assays.
D-dimer as a screening test for deep vein thrombosis
Surgery is a high risk setting for the development of venous thromboembolism. There has been much performed D-dimer assays in 45 trauma victims. ELISA (Agen Diagnostica, USA) and the SimpliRED D-dimer levels were elevated in 77% of patients at diagnosis and levels were proportional to the patients injury severity score.
The findings of these studies are consistent with earlier trials [34] , which demonstrated levels of Ddimer were elevated following major surgical procedures. In considering use of D-dimer as a post-operative screen, considerably higher cut-off values for D-dimer must be used than when D-dimer is used as a diagnostic test in patients with symptoms of venous thromboembolism. The utility of relying of postoperative D-dimer levels as a screening test for deep vein thrombosis has never been evaluated in a management study. However, using D-dimer cut-off values determined by trials of symptomatic patients are likely to be of very low yield following surgery due to the very low specificity of the assays in this setting caused by the post-operative rise in D-dimer.
Use of D-Dimer to diagnose recurrent venous thromboembolism
Logically, D-dimer should be a very useful test to assist with the evaluation of patients with suspected recurrent venous thromboembolism. D-dimer results will usually return to normal following three months of antithrombotic therapy for the treatment of acute venous thromboembolism [34] . However, no published study has confirmed the utility of D-dimer in excluding the diagnosis of recurrent disease and management studies are required to confirm the safety and effectiveness of this approach.
Which D-dimer assay to choose?
There are a wide variety of D-dimer assays from which to choose for use to exclude or minimize the need for other diagnostic testing in patients with suspected venous thromboembolism. Many of these assays are fully automated and provide results within minutes, overcoming some of the pitfalls with the initial D-dimer tests.
It is important for clinicians to be aware of the diagnostic characteristics of D-dimer assays in use at their institution. If the decision is made that a D-dimer test with the highest negative predictive value should be used to minimize the number of false negative results then an ELISA based assay or a very sensitive immunoturbimetric assay should be chosen. Although one study has suggested it is safe to exclude the diagnosis of venous thromboembolism on the basis of a negative D-dimer [10] , this finding should be confirmed in larger multicenter studies before it is considered the standard of care. In the interim, clinicians should exercise caution in excluding the diagnosis of venous thromboembolism in patients with negative D-dimer results when the clinical suspicion is high. The major drawback of the highly sensitive D-dimer assays is their poor specificity which limits negative results to a relatively small proportion of the patient population (Table 3 ). The use of these Ddimer assays may not be warranted in hospitalized patients because of their very low specificity.
Whole blood agglutination and latex agglutination assays may prove to be a reasonable choice for D-dimer but their lower sensitivity limits their safety. These assays are not sufficiently sensitive to be used in isolation as a test to exclude the diagnosis of venous thromboembolism. They should be applied only to patient populations in which another independent parameter has lowered the prevalence of venous thromboembolism. Such parameters could include consideration of low clinical probability or negative radiographic investigations [35] . It is incumbent that with the use of less sensitive D-dimers, clinicians be well educated about the predictive values of the various test results. The diagnosis of venous thromboembolism should not be excluded on the basis of a negative D-dimer result if the clinical suspicion remains moderate or high.
The major advantage of these less sensitive D-dimer assays is their higher specificity (Table 3 ). The rate of true negative assay results are significantly higher with these less sensitive D-dimers than with ELISA assays. This higher specificity enables the potential to exclude or minimize the need for radiographic testing in much larger proportions of the population.
